Drilldown: Medicines
Appearance
Use the filters below to narrow your results.
Potent 5-HT2A agonist; no oral activity (1) ·
Prodrug of LSD; 5-HT2A agonist (1) ·
'"`UNIQ--vote-0000124C-QINU`"' The 400 mg/d dose for migraine prophylaxis is supported by randomized trials (Schoenen 1998) and remains a low-risk evidence-based supplement option. Characteristic bright-yellow urine fluorescence with high-dose oral supplementation. (1)
Showing below up to 3 results in range #1 to #3.


